NIH-funded research R01 grant

Understanding how certain cells in the lungs help with tissue organization and cell development

Official title: Role of alveolar fibroblasts in extracellular matrix organization and alveolar type 1 cell differentiation

Funded at Cincinnati Childrens Hosp Med Ctr · NIH-10912833 · Data updated 2026-11-12

This study is looking at how certain cells in the lungs help build and repair lung tissue, with the goal of finding new treatments for conditions like Bronchopulmonary Dysplasia in premature babies and improving lung healing in adults.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCincinnati Childrens Hosp Med Ctr
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startSeptember 1, 2023
Project endJuly 31, 2027
Funding year2024
Award (this year)$768,391
NIH project number5R01HL167030-02
Project IDNIH-10912833 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include premature infants at risk for Bronchopulmonary Dysplasia and adults with lung regeneration needs.

Less likely to help

Patients with stable lung conditions who do not require intervention or have no history of lung injury may not benefit from this research.

What this research studies

This research investigates the role of alveolar fibroblasts in the lungs, focusing on how they contribute to the organization of the extracellular matrix and the differentiation of alveolar type 1 cells. By examining the molecular mechanisms that regulate these processes, the research aims to develop therapies for conditions like Bronchopulmonary Dysplasia (BPD) in premature infants and to enhance lung regeneration in adults. The study utilizes advanced techniques to analyze changes in fibroblast function during lung development and repair, providing insights that could lead to innovative treatments.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that improve lung health and regeneration for patients with BPD and other lung conditions.

How similar studies have gone: Other research has shown promising results in understanding fibroblast functions in lung development, indicating that this approach has potential for success.

Where this research is happening

  • Cincinnati Childrens Hosp Med Ctr
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Perl, Anne-Karina Theresia — Cincinnati Childrens Hosp Med Ctr
  • Study coordinator: Perl, Anne-Karina Theresia

Related research

Other NIH-funded projects on the same topics.

  • Accelerating Rheumatic Heart Disease Prevention in Uganda

    A program to find people with rheumatic heart disease in Ugandan communities and give them preventive care close to home.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11645314

  • Enhanced surveillance network to track childhood vaccines and viral infections in kids

    A nationwide pediatric surveillance network will closely watch how common viruses and vaccines affect children’s health, using standard protocols at hospital and ED sites.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11624109

  • Advancing CNS drug delivery through epigenetic tweaks

    A medical research project aims to help people with lysosomal storage disorders by improving how treatments reach the brain.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11617801

  • Spina Bifida Registry for Better Clinic Care

    A national registry project aims to improve care for people with spina bifida by collecting and sharing data from multidisciplinary clinics to guide evidence-based practices.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11616587

  • Hydroxyurea to help children with sickle cell anemia in Africa

    A pediatric study tests hydroxyurea treatment for young children with sickle cell anemia in several African countries to see if it can reduce illness and improve health.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606512

  • Hydroxyurea for Children with Sickle Cell in Africa

    A pilot study tests hydroxyurea in young children with sickle cell disease across several African countries to see if it can reduce illness and hospital visits.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606510

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.